USFDA issues EIR for Unit 1 of Apitoria Pharma Back
Aurobindo Pharma has received the Establishment Inspection Report (EIR) issued by the USFDA classifying Unit 1 of Apitoria Pharma, a wholly owned subsidiary of the company as 'Voluntary Action Indicated (VAI)'.